NINDS Advisory Council Agenda - February 14-15, 2019

NINDS Advisory Council Agenda - February 14-15, 2019

National Advisory Neurological Disorders and Stroke Council

204th Meeting

February 14-15, 2019

Building 35, John Edward Porter Neuroscience Research Center
Conference Room 620/630/640
35 Convent Drive
Bethesda, Maryland 20892

NIH Videocast Website:


February 14, 2019


12:30 p.m.

I.  Call to Order and Opening Remarks
       Dr. Walter Koroshetz, Chairperson, Director, NINDS

12:35 p.m.

II.  Report of the Director, Division of Extramural Activities, NINDS
       Dr. Robert Finkelstein, Executive Secretary, NANDS Council

       A. Consideration of Minutes of September 12-13, 2018, Meeting

       B. Confirmation of Dates for Future Council Meetings

                                                Thurs. & Fri., May 23-24, 2019  

                                                Wed. & Thurs. September 4-5, 2019                 

                                                Wed. & Thurs. February 5-6, 2020                    

                                                Wed. & Thurs. May 27-28, 2020

                                                Wed. & Thurs. September 9-10, 2020                                            

       C.   Other Items

                          Council Operating Procedures

                          Expedited Review Process

                          Extramural Announcements

12:45 p.m.

III.  Report of the Director, NINDS
       Dr. Walter Koroshetz

1:05 p.m.

IV.  Discussion of Director’s Report

1:20 p.m.

V.  Report from the Society for Neuroscience
     Dr. Diane Lipscombe, President, Society for Neuroscience, Professor of Neuroscience and Director of the Brown Institute for Brain Science, Brown University

1:50 p.m.

VI. Overview of the Office of Training & Workforce Development Activities
      Dr. Stephen Korn, Office of Training & Workforce Development

3:20 p.m.


3:35 p.m.

VII. Overview of the Division of Clinical Research Activities
        Dr. Clinton Wright, Division of Clinical Research

5:05 p.m.

VIII. Initiatives Requiring Concept Clearance:

          - Renewal of the Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (P50) Program
            Dr. Glen Nuckolls, Division of Neuroscience

          - NINDS DNA and Cell Line Repository
            Dr. Ran Zhang, Division of Neuroscience

          - Reevaluation of the NINDS P30 (Research Core) Mechanism
            Dr. Timothy LaVaute, Division of Neuroscience

5:45 p.m.

IX. IC Reports Monitoring Adherence to the NIH Policy on the Inclusion of Women and Minorities in Clinical Research
      Dr. Carolina Mendoza-Puccini, Division of Clinical Research

6:00 p.m. **


February 15, 2019

8:30 a.m.


This portion of the meeting is being closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

X.  Review of Conflict of Interest, Confidentiality, and Council Procedures
      Council Consideration of Pending Applications
      Dr. Robert Finkelstein, Executive Secretary, NANDS Council


1:00 p.m. **

** This time is tentative